Industry
New Technology Licensed to Beckman Coulter
Under the terms of a licensing agreement signed by the two parties, Critical Therapeutics has granted certain rights in its patents, patent applications, and other intellectual property relating to its high mobility group box protein 1 (HMGB1) technology to Beckman Coulter More...15 Feb 2005
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
In Other News
Oxford and Pfizer to Develop POC Tests
Reagent Technology Licensed to Olympus Diagnostica
MorphoSys Extends Deal with Schering
Trestle to Acquire Interscope Technologies
Diagnocure Acquires Rights to Breast Cancer Markers
Biofile Acquires Biofons' ELISA Products
Pelikan Technologies Acquires Inventus BioTech
Iceland Genomics and Aclara in Biomarker Alliance
Collaboration on Lab Order Entry System
Paris Hosts Journees Internationales de Biologie
MedCap Acquires Rights to Syphilis Test
SomaLogic Receives Innovation Award
Odyssey Licenses in Vitro Technology to Panbio
Parent of Fujirebio to Integrate with SRL in Japan
Pall and Kawasumi Announce Marketing Agreement
Bio-Rad in HIV Licensing Deal with Calypte
David Pall, Founder of Pall Corporation, Dies at 90.
Escalon Acquires About 94% of Drew Scientific
Collaboration to Identify Autoimmune Markers
Boston Biomedica Sells Diagnostics and Biotech Divisions
Quest to Market Test for Metastatic Breast Cancer
Alliance to Promote Genetic Tests, Research
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.